Biology of CD94/NKG2A and HLA-E

Haanen, Cerundolo et al, 2018. NKG2A, a New Kid on the Immune Checkpoint Block Cell

Thorbald van Hall et al, 2018. NKG2A Blockade Potentiates CD8 T Cell Immunity Cell

Sheu et al, 2005. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma Cancer Res.

Platonova et al, 2011. Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma Cancer Res.

Gunturi et al, 2005. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells European journal of immunology

Subscribe to Biology of CD94/NKG2A and HLA-E

Company
Science
Products
- Pipeline overview
- ------------------
- Lacutamab
- IPH4502
- Monalizumab
- Other Clinical Stage Assets
  - IPH6501
  - IPH6101
  - IPH6401
  - IPH5201
  - IPH5301
Partnering
Investors
Media
Careers